Clinical Trial Update: Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 prospective study is evaluating frontline antibiotic therapy for HP-negative gastric MALT lymphoma; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Mucosa-associated Lymphoid Tissue Lymphoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: MALT Lymphoma of Stomach | Phase 2 | Status: NOT_YET_RECRUITING